/channels-contribute/taxonomy/term/339/all en /channels-contribute/channels/news/quality-control-mitochondria-defense-against-disease-232521 <p>Scientists from the Montreal Neurological Institute and Hospital in Canada have discovered that two genes linked to hereditary Parkinson’s disease are involved in the early-stage quality control of mitochondria. The protective mechanism, which is reported in <em>The EMBO Journal</em>, removes damaged proteins that arise from oxidative stress from mitochondria. </p> Tue, 21 Jan 2014 16:27:26 +0000 anita.kar@mcgill.ca 913 at /channels-contribute /channels-contribute/channels/news/unleashing-watchdog-protein-226719 <h3>Research opens door to<b> </b>new drug therapies for<b> </b>Parkinson’s disease</h3> <p>ºÚÁϲ»´òìÈ University researchers have unlocked a new door to developing drugs to slow the progression of Parkinson’s disease. Collaborating teams led by Dr. Edward A. Fon at the Montreal Neurological Institute and Hospital -The Neuro, and  Dr. Kalle Gehring  in the Department of Biochemistry at the Faculty of Medicine, have discovered the three-dimensional structure of the protein Parkin.</p> Thu, 09 May 2013 18:38:14 +0000 anita.kar@mcgill.ca 730 at /channels-contribute /channels-contribute/channels/news/clinician-scientists-neuro-receive-funding-parkinson%E2%80%99s-and-hiv-research-224829 <p><span><span>November 27, 2012 - Clinician-scientists take a unique, integrated approach that is essential to advancing science and medicine. Problems encountered in the clinic inspire research and new findings from the labs are directly applied to patients’ needs. The integrated model is a hallmark of the Montreal Neurological Institute and Hospital – The Neuro, at ºÚÁϲ»´òìÈ University and the MUHC and is now being replicated worldwide. Two clinician-scientists at The Neuro have been awarded grants today to further research on Parkinson’s disease and HIV/AIDS. </span></span></p> Tue, 05 Feb 2013 21:44:33 +0000 anita.kar@mcgill.ca 673 at /channels-contribute